Comment: Comparison of Hmg-Coa Reductase Inhibitors

Abstract

Get full access to this article

View all access options for this article.

References

Hsu

, Spinier

, Johnson

. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacother 1995; 29: 743–59.

Davey Smith

, Song

, Sheldon

. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993; 306: 1367–73.

Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9.

Shaughnessy

, Slawson

. Simvastatin decreases mortality (abstract). J Fam Pract 1995; 40: 498–9.

Silberberg

. After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart disease. Aust N Z J Med 1994; 24: 717–21.